Diagnostic Medical Systems: Q1 2026 Revenue of €10M

Diagnostic Medical Systems (DMS Group) announced consolidated revenue of €10 million for the first quarter of 2026. This represents an 8% decrease compared to the previous year. The radiology sector experienced a slight decline of 5%, while bone densitometry fell by 20%. Despite this cyclical slowdown, DMS Group anticipates a return to growth in the second quarter. The company is striving to outperform the medical imaging market, primarily internationally, and expects to maintain its annual growth trajectory.

Geographically, revenue in North America declined slightly, offset by strong results in South America. Europe experienced an 18% drop, particularly in Italy, despite slight growth in France. The Middle East also saw a decrease in revenue. DMS Group is preparing to launch its new ONYX mobile radiology system, with sales expected in the third quarter.